NCT01471431

Brief Summary

The objective of this study is to determine whether use of the spontaneous breathing trial allows for earlier successful extubation of very low birth weight (VLBW) infants who are intubated for \>48 hours and have not yet been successfully extubated (extubated \>7 days).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 16, 2011

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

June 7, 2016

Status Verified

September 1, 2015

Enrollment Period

4.7 years

First QC Date

November 10, 2011

Last Update Submit

June 3, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • time to successful extubation

    The time from intubation (if \>48 hours) to successful extubation (if \> 7 days) as evaluated at 34 weeks postmenstrual age (gestational age + chronologic age)

    34 weeks postmenstrual age

Secondary Outcomes (2)

  • bronchopulmonary dysplasia

    36 weeks postmenstrual age

  • extubation failure rate

    34 weeks postmenstrual age

Study Arms (2)

Spontaneous breathing trial

EXPERIMENTAL

The spontaneous breathing trial will determine the extubation readiness of the subject.

Other: spontaneous breathing trial

Usual care

NO INTERVENTION

Subjects will be extubated using usual care, without the use of the spontaneous breathing trial.

Interventions

The SBT is performed daily on rounds if an infant is on conventional ventilation and meets all predetermined ventilator criteria (set ventilator rate ≤30, peak inspiratory pressure (PIP) delivered on mandatory breaths ≤20 cm H2O, pressure support (PS) ≤8 cm H2O, positive end-expiratory pressure (PEEP) ≤6 cm H2O, inspired fractional oxygen (FiO2) ≤0.40). During the SBT, the ventilator rate and pressure support are set to zero, and the infant is maintained on continuous positive airway pressure (CPAP) alone via the endotracheal tube. The trial duration is 3 minutes, unless an infant fails before the trial is complete. Failure is defined as bradycardia \<100 for \>15 seconds or oxygen saturation by pulse oximetry \<85% despite a 15% increase in FiO2. If an infant passes the SBT, they are extubated within 3 hours. If an infant fails the SBT, they remain intubated and the daily application of the SBT continues as long as the minimum ventilator criteria are met.

Spontaneous breathing trial

Eligibility Criteria

Age48 Hours - 14 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Birthweight \>500g and\<1500g.
  • Postmenstrual age \<34 weeks
  • Mechanically ventilated \>48 hours
  • Never successfully extubated

You may not qualify if:

  • Congenital heart disease (other than patent ductus arteriosus (PDA), patent foramen ovale (PFO), and restrictive ventricular septal defect (VSD)
  • Known or suspected airway anomalies
  • Severe congenital malformations
  • Need to remain intubated for other reasons (i.e. having surgery)
  • Has met SBT criteria on previous calendar day (after 48 hrs of ventilation, PIP≤18, PEEP≤6, FiO2≤40%, Rate≤30, PS≤8)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Hospital of the University of Pennsylvania

Phialdelphia, Pennsylvania, 19104, United States

Location

Pennsylvania Hospital

Philadelphia, Pennsylvania, 19107, United States

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Ann-Johanna Giaccone, MD

    University of Pennsylvania

    STUDY DIRECTOR
  • Barbara Schmidt, MD, MSc

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 10, 2011

First Posted

November 16, 2011

Study Start

August 1, 2011

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

June 7, 2016

Record last verified: 2015-09

Locations